33278043|t|Brain Microglial Activation Increased in Glucocerebrosidase (GBA) Mutation Carriers without Parkinson's disease.
33278043|a|BACKGROUND: Glucocerebrosidase gene mutations are a common genetic risk factor for Parkinson's disease. They exhibit incomplete penetrance. The objective of the present study was to measure microglial activation and dopamine integrity in glucocerebrosidase gene mutation carriers without Parkinson's disease compared to controls. METHODS: We performed PET scans on 9 glucocerebrosidase gene mutation carriers without Parkinson's disease and 29 age-matched controls. We measured microglial activation as 11 C-(R)-PK11195 binding potentials, and dopamine terminal integrity with 18 F-dopa influx constants. RESULTS: The 11 C-(R)-PK11195 binding potential was increased in the substantia nigra of glucocerebrosidase gene carriers compared with controls (Student t test; right, t = -4.45, P = 0.0001). Statistical parametric mapping also localized significantly increased 11 C-(R)-PK11195 binding potential in the occipital and temporal lobes, cerebellum, hippocampus, and mesencephalon. The degree of hyposmia correlated with nigral 11 C-(R)-PK11195 regional binding potentials (Spearman's rank, P = 0.0066). Mean striatal 18 F-dopa uptake was similar to healthy controls. CONCLUSIONS: In vivo 11 C-(R)-PK11195 PET imaging detects neuroinflammation in brain regions susceptible to Lewy pathology in glucocerebrosidase gene mutation carriers without Parkinson's.   2020 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
33278043	41	59	Glucocerebrosidase	Gene	2629
33278043	61	64	GBA	Gene	2629
33278043	92	111	Parkinson's disease	Disease	MESH:D010300
33278043	125	143	Glucocerebrosidase	Gene	2629
33278043	196	215	Parkinson's disease	Disease	MESH:D010300
33278043	329	337	dopamine	Chemical	MESH:D004298
33278043	351	369	glucocerebrosidase	Gene	2629
33278043	401	420	Parkinson's disease	Disease	MESH:D010300
33278043	480	498	glucocerebrosidase	Gene	2629
33278043	530	549	Parkinson's disease	Disease	MESH:D010300
33278043	616	632	11 C-(R)-PK11195	Chemical	-
33278043	657	665	dopamine	Chemical	MESH:D004298
33278043	690	699	18 F-dopa	Chemical	MESH:C043437
33278043	731	747	11 C-(R)-PK11195	Chemical	-
33278043	807	825	glucocerebrosidase	Gene	2629
33278043	981	997	11 C-(R)-PK11195	Chemical	-
33278043	1111	1119	hyposmia	Disease	MESH:D000086582
33278043	1143	1159	11 C-(R)-PK11195	Chemical	-
33278043	1233	1242	18 F-dopa	Chemical	MESH:C043437
33278043	1304	1320	11 C-(R)-PK11195	Chemical	-
33278043	1341	1358	neuroinflammation	Disease	MESH:D000090862
33278043	1391	1405	Lewy pathology	Disease	MESH:D005598
33278043	1409	1427	glucocerebrosidase	Gene	2629
33278043	1459	1470	Parkinson's	Disease	MESH:D010300
33278043	1492	1510	Movement Disorders	Disease	MESH:D009069
33278043	1573	1604	Parkinson and Movement Disorder	Disease	MESH:D009069
33278043	Association	MESH:D005598	2629
33278043	Association	MESH:C043437	MESH:D004298
33278043	Association	MESH:D004298	2629
33278043	Association	MESH:D000090862	2629
33278043	Association	MESH:D010300	2629

